Related Experiment Videos
[Glomerulonephritis associated with hepatitis c virus infection]
Insights
Hepatitis C virus (HCV) infection is linked to glomerulonephritis (GN) in patients. Treating HCV infection can improve kidney function, highlighting the importance of viral marker testing in GN patients.
Area of Science:
- Nephrology
- Hepatology
- Virology
Context:
- Hepatitis C virus (HCV) infection is a global health concern.
- Glomerulonephritis (GN) can be associated with chronic infections.
- The link between HCV and GN requires further investigation.
Purpose:
- To investigate the association between hepatitis C virus (HCV) infection and glomerulonephritis (GN).
- To evaluate the clinical and laboratory findings in patients with HCV-related GN.
- To assess the impact of antiviral therapy on renal outcomes in HCV-infected GN patients.
Summary:
- Four patients with glomerulonephritis (GN) associated with hepatitis C virus (HCV) infection were studied.
- All patients presented with viremia, cryoglobulinemia, hematuria, and proteinuria.
- Renal biopsies showed membranoproliferative GN in three patients and mesangial proliferative GN in one.
- Two patients treated with interferon and ribavirin showed significant clinical and laboratory improvement.
- These findings suggest viral involvement in renal disease and support the importance of testing for viral markers in GN patients.
Impact:
- Early detection of viral markers in GN patients can guide therapeutic strategies.
- Antiviral treatment for HCV may improve renal outcomes in affected patients.
- This study underscores the importance of a multidisciplinary approach in managing HCV-related kidney disease.
Abstract:
We report 4 patients with glomerulonephritis (GN) associated with hepatitis C virus (HCV) infection seen between August 1993 and July 1996. Two of them were male and median age was 41 years. Anti-HCV was detected by enzyme-immunoassay and HCV-RNA by PCR. Serum cryoglobulins, 24-hour proteinuria, and erythrocyte dismorphism were also determined. Viremia, cryoglobulinemia, hematuria and proteinuria were observed in all patients. Liver biopsies revealed inflammatory activity in 3 cases, and renal biopsies revealed membranoproliferative glomerulonephritis in 3 patients and mesangial proliferative glomerulonephritis in 1 patient. Two patients are on specific therapy for HCV infection (IFN in combination with ribavirin) and have presented clinical and laboratory improvement. The occurrence of active liver disease and viremia concurrent with urinary alterations suggests viral involvement in renal disease, a conclusion supported by the by improvement of urinary alterations observed after treatment for HCV. We conclude that the search for viral markers in patients with GN is important since their detection could change the therapeutic approach.